Innovator’s Spotlight: MedTech Founders on Stage

Join us for a special evening as we spotlight groundbreaking innovators in MedTech! "Innovator’s Spotlight: MedTech Founders on Stage" will feature three dynamic startup founders—from Kortuc, Rosette Health, and Universal Brain—whose technologies are set to revolutionize healthcare. This inspiring panel discussion will explore their journeys, breakthroughs, and the future of MedTech, offering exclusive insights into what it takes to innovate in the highly competitive and impactful healthcare industry.

💡 Why You Should Attend:

• Discover Game-Changing Innovations: Learn how Kortuc, Rosette Health, and Universal Brain are addressing critical challenges in healthcare through cutting-edge MedTech solutions.
• Connect with Experts: Gain unique perspectives from visionary founders about the journey of bringing MedTech innovations to market.
• Expand Your Network: Meet startup founders, healthcare professionals, investors, and MedTech enthusiasts during our networking session.
• Stay Ahead in MedTech: Understand the emerging trends shaping the future of medical technology.

👍 Who Should Attend:

• MedTech startup founders, entrepreneurs, and innovators.
• Investors who are interested in healthcare and technology.
• Professionals and leaders in the healthcare and technology industries.
• Students and researchers who are eager to learn about the MedTech ecosystem.

Don’t miss this opportunity to hear firsthand from MedTech innovators and gain valuable insights into the industry’s future.

Light refreshments will be provided.

📌Register now to secure your spot, as space is limited!

We look forward to seeing you there!

Can't join us in person? Register for the virtual live streaming option and experience the event in real time from anywhere!

Hosted by JETRO at Japan Innovation Campus. Powered by AlchemistX. Supported by METI.

*By registering for this event, you consent to the sharing of your contact information with the event organizer, JETRO, and JIC, for administrative and communication purposes. Your information will be handled in accordance with our privacy policy. Additionally, you also agree that JETRO, JIC, and all affiliated organizations reserve the right to take photos and video recordings during the event. These may be used for promotional purposes, including social media, websites, and other marketing channels. If you have any questions or concerns about the use of your contact information and/or do not wish to be photographed or recorded, please inform the event staff upon arrival and contact us at [email protected]. Thank you for your understanding and cooperation.

About the Speakers:

(Moderator)

As a C-Suite Executive, JC scaled multiple digital health startups towards successful exits, including C3i, which he helped scale from 20 employees in NYC to 1,500 globally.

Today, JC advises early-stage digital health companies with their product, go-to-market & operational strategies, including the adoption of Generative AI in healthcare.

Over the years, JC has developed a broad knowledge and network across multiple segments of healthcare which translates into more potential opportunities for his clients.

JC operates in Life Sciences, Payers, Employers, Providers, Labs, Clinical Trials, Behavioral Health, Diabetes, Patient Advocacy, Orphan Drugs, Med Devices and more.

As a fractional executive, JC has hands-on experience managing multiple functions as a member of the C-Suite. His clients leverage his experience to augment their management team across multiple functions at a fraction of the cost.

On a personal level, JC is an active volunteer for mental and physical disability causes (Best Buddies, Paralyzed Veterans of America) and operates both MyRareData, a pro-bono organization that helps rare disease groups leverage digital health and Mental Health For Rare, a non-profit dedicated to expanding access to Mental Health for Rare Patients and families.

is the CEO of KORTUC Inc. KORTUC Inc is a biotech company developing a novel radiosensitizer to solve the fundamental limitation of conventional cancer radiotherapy and to improve its effectiveness. The technology has origin in Japan. Their drug consists mainly of hydrogen peroxide in a prefilled syringe format to inject directly into tumors right before radiotherapy. H2O2 makes radioresistant tumors radiosensitive. Their first clinical trial is ongoing for locally advanced/recurrent breast cancer as registrational Phase 2 study led by the UK Institute of Cancer Research in UK and India. They will soon start clinical trials for cervical and rectal cancers globally. They are also exploring another opportunity of our drug as immunostimulant in immunotherapy by activating anti-tumor immune response.

is a seasoned entrepreneur and product leader with extensive experience in the technology and healthcare industries. She is currently the Co-founder and CEO of Rosette Health, a company she started in August 2023.

is the Founder and CEO of Universal Brain and is working on developing a neuroscience-based psychiatric platform to establish the diagnosis and treatment of mental disorders.

In the psychiatry department of a university hospital, he was intensely shocked to find that the prognosis of patients varied greatly depending on the physician's skill. He founded Universal Brain to establish treatment and diagnosis based on the analysis of physiological data. At Universal Brain, he engages in developing an innovative EEG headset and algorithms to deliver better care to patients with psychiatric disorders.

Universal Brain has raised $4.2 million in seed funding alone and has been chosen to join the 2023 MedTech Innovator Accelerator Cohort.

Host or Publisher JETRO San Francisco